Baxter Reports Third-Quarter 2023 Results

Third-quarter revenue from continuing operations of $3.71 billion increased 3% on a reported basis and 2% on a constant currency basis, ahead of the company’s previously issued...

Related Keywords

Ukraine ,Israel ,United States ,Argentina ,Switzerland ,Australia ,Gaza ,Israel General ,Ahmedabad ,Gujarat ,India ,Swiss ,Welch Allyn ,Joee Almeida ,Warburg Pincus ,Baxter Biopharma Solutions ,Development Expenses ,Care Connectivity Solutions ,Baxter International Inc ,Biopharma Solutions ,Linkedin ,Facebook ,European Union ,European Medicines Agency ,Department Of Justice ,Surgical Solutions ,Advent International ,Biopharma Solutions Divestiture ,Centers For Medicare Medicaid Services ,Foreign Exchange ,Mission To Save ,Rom Holdings Inc ,Connectivity Solutions ,Simtra Biopharma Solutions ,Baxter International ,Medication Delivery ,Clinical Nutrition ,Patient Support Systems ,Renal Care ,Kidney Care ,Chronic Therapies ,Peritoneal Dialysis ,Acute Therapies ,Medical Products ,Healthcare Systems ,Simtra Biopharma ,Welch Allyn Panoptic Plus ,Examiner Pro System ,Examiner Pro ,Welch Allyn Spot Vision Screener ,Vision Screener ,Regulations K ,Federal Trade Commission ,Medicaid Services ,Attorney General ,Panoptic Plus ,Spot Vision Screener ,Continuing Operations Before Income ,Administrative Expenses ,Tax Expense ,From Continuing Operations ,From Discontinued Operations ,Baxter Stockholders ,Earnings Per Share ,Continuing Operations ,Discontinued Operations ,Operating Expense ,From Continuing Operations Before Income Taxes ,Hill Rom Holdings ,False Claims Act ,Months Ended September ,Operating Income ,Operating Segment ,Segment Net ,Segment Sales ,Cash Flow ,Free Cash ,Total Baxter ,Net Sales Growth As Reported ,Constant Currency Sales ,Three Months Ended September ,Nine Months Ended September ,Fourth Quarter ,Full Year ,Projected Fourth Quarter ,Earnings Per ,Markets ,